Imaging, biomarkers, and vascular cognitive impairment in China: Rationale and design for the VICA study
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.14352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Mei Cui und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Biomarkers, Cerebral Small Vessel Diseases, Cognitive Dysfunction, Neuroimaging. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Scientific and Technological Innovation 2030-Major Projects, National Key Research and Development Program of China.
Abstract (Originalsprache)
INTRODUCTION Vascular cognitive impairment (VCI) is highly heterogeneous, with unclear pathogenesis. Individuals with vascular risk factors (VRF), cerebral small vessel disease (CSVD), and stroke are all at risk of developing VCI. To address the growing challenges posed by VCI, the “Vascular, Imaging and Cognition Association of China” (VICA) was established. METHODS VICA aims to recruit 10,000 participants, including 2000 with VRF, 3000 with CSVD, and 5000 stroke patients, to form a nationwide multicenter cohort. The study integrates clinical, neuroimaging, and multi‐omics data to better understand VCI heterogeneity, improve disease prediction, and ensure timely diagnosis. RESULTS VICA has screened 2045 eligible VRF participants from six communities in Wuhan, Shanghai, and Taizhou, along with 602 CSVD and 1269 stroke patients from 135 hospitals nationwide. Baseline enrollment and follow‐up work are still ongoing. DISCUSSION Establishing a high‐quality longitudinal cohort is crucial for understanding VCI pathogenesis and developing novel markers for early screening and diagnosis. Highlights Establish a large‐scale prospective longitudinal cohort comprising 10,000 participants, focusing on the high‐risk population of vascular cognitive impairment (VCI) in China. Establish a nationwide three‐tier medical network, make full use of resources, and achieve extensive enrollment of patients with cerebral small vessel disease and stroke patients. Utilize multimodal imaging and biomarkers to lay the foundation for constructing more‐precise risk models. Introduce eye movement and gait analysis as new methods for assessing cognitive function. Use positron emission tomography to further investigate the interaction between vascular factors and neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
- MOE Frontiers Center for Brain Science, National Center for Neurological Disorders, Shanghai, China.
- Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, China.
- Department of Neuropsychology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Förderung
- National Key R&D Program of China
- Scientific and Technological Innovation 2030-Major Projects
- National Key Research and Development Program of China
Zitieren
APA
Cui, M., Jin, Z., Wang, Y., Jiang, J., Peng, S., Wei, Q., Zhang, S., Tuo, Q., Xie, J., Leng, H., Wang, H., Zhao, Y., Lei, P., Xu, J., Wang, K., Zhang, J., Jiang, Y., Ding, D., Xie, F., …, & VICA Investigators (2024). Imaging, biomarkers, and vascular cognitive impairment in China: Rationale and design for the VICA study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14352
Vancouver
Cui M, Jin Z, Wang Y, Jiang J, Peng S, Wei Q, et al. Imaging, biomarkers, and vascular cognitive impairment in China: Rationale and design for the VICA study. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14352
BibTeX
@article{Cui2024,
author = {Cui, Mei and Jin, Zishuo and Wang, Yingzhe and Jiang, Jiwei and Peng, Sisi and Wei, Qiang and Zhang, Shuting and Tuo, Qingzhang and Xie, Junchao and Leng, Haixia and Wang, Hongxing and Zhao, Yanxin and Lei, Peng and Xu, Jun and Wang, Kai and Zhang, Junjian and Jiang, Yanfeng and Ding, Ding and Xie, Fang and Yu, Jintai and Dong, Qiang and VICA Investigators, VICA Investigators},
title = {Imaging, biomarkers, and vascular cognitive impairment in China: Rationale and design for the VICA study},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.14352}
}
EUVIMED